Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) have shown to decrease mortality and cardiovascular morbidity especially in high-risk patients after acute myocardial infarction (AMI). Aim of this study…
In their report regarding the rationale of naming this right ventricular disease entity with a high arrhythmogenic susceptibility related to sudden death, Fontaine and Chen claim that arrhythmogenic right ventricular…
The corresponding author Dr. Zhang has included Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC) in his affiliation. The corresponding author affiliation “a” should read…
On page 1225, in Table 3, the value in Variable and CABG Surgery, Y (n = 122) columns, “Intraprocedural death, 9 (7.9)” should be “VARC in hospital cardiac death, 9 (7.4)”.
Chronic kidney disease (CKD) and atrial fibrillation (AF) frequently coexist. However, the extent to which CKD increases the risk of thromboembolism in patients with nonvalvular AF and the benefits of…
Cardiovascular disease (CVD) remains still the leading cause of death in the United States, and it is estimated to be the leading cause of death in the developing countries by…
Wong et al recently published a report using the UK Prospective Diabetes Study risk engine to estimate the 10-year probability of coronary heart disease (CHD) events for US adults with type…
Understanding the perspective of early-career cardiologists is important to design effective responses to the challenges in modern cardiovascular (CV) training programs. We conducted a web-based survey on a total of…
A paradoxical negative association between obesity and the plasma B-type natriuretic peptide (BNP) level has been firmly established. An individual’s fat mass increases and muscle mass decreases with aging. Because…
